HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

From remote Bulgarian villages to Estonian islands, a silent revolution is underway—one that promises to reshape not just ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

IIT Delhi released its Research Impact Report on the occasion of its 67th Foundation Day on Monday The report talks about the Institute contribution to nat ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

VanWassenhove has sleep apnea, which affects her heart rate and breathing. That prompted her to keep a close eye on her watch ...

IIT Delhi incubated 147 startups in 7 years, focusing on life sciences, green tech, and other key areas. The institute also ...

By taking action with your doctor, they can properly diagnosis health issues, and help develop an action plan for your life.

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$77.71 billion in 2024 and an impressive US$110.39 billion by ...

The research team set out to develop a novel AI system capable of comprehensive reporting for all major findings from any set of echocardiography videos, training it on almost 34,000 ECG tests and ...

EEG Signal Acquisition and Preprocessing: • Advances in EEG hardware for real-world, portable BCI systems ... Integration of ...